OPTIPRANOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Optipranolol, and what generic alternatives are available?
Optipranolol is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in OPTIPRANOLOL is metipranolol hydrochloride. There are two drug master file entries for this compound. Additional details are available on the metipranolol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OPTIPRANOLOL?
- What are the global sales for OPTIPRANOLOL?
- What is Average Wholesale Price for OPTIPRANOLOL?
Summary for OPTIPRANOLOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 3,947 |
DailyMed Link: | OPTIPRANOLOL at DailyMed |
US Patents and Regulatory Information for OPTIPRANOLOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | OPTIPRANOLOL | metipranolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019907-001 | Dec 29, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |